Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US7553863 | PAR PHARM INC | Ultrapure 4-methylpyrazole |
Jun, 2027
(4 years from now) |
Market Authorisation Date: 04 December, 1997
Treatment: NA
Dosage: INJECTABLE;INJECTION
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic